Back to Results
First PageMeta Content
Bristol-Myers Squibb / Cetuximab / Tyrosine kinase receptors / Immune system / Symphogen / Monoclonal antibody therapy / Monoclonal antibodies / HER2/neu / Zalutumumab / Immunology / Biology / Medicine


Advancing the Frontier of Antibody Therapeutics Kirsten Drejer, PhD Chief Executive Officer
Add to Reading List

Document Date: 2014-01-14 13:28:11


Open Document

File Size: 1,82 MB

Share Result on Facebook
UPDATE